Tallenna
Phosphoinositide 3-kinase in Health and Disease
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress.
- Alaotsikko
- Volume 1
- Toimittaja
- Christian Rommel, Bart Vanhaesebroeck, Peter K. Vogt
- Painos
- 2011 ed.
- ISBN
- 9783642265228
- Kieli
- englanti
- Paino
- 310 grammaa
- Julkaisupäivä
- 7.11.2012
- Sivumäärä
- 310
